MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) will present its latest advances in soft-tissue reconstruction at Piper Sandler’s 37th Annual Healthcare Conference, the company announced, marking another opportunity for the commercial-stage medtech firm to showcase its growing product portfolio to investors and industry leaders.
The company’s management team is scheduled to present at 2:30 p.m. ET on Dec. 3, 2025. A live and archived webcast of the session will be available through TELA Bio’s investor relations site at ir.telabio.com.
TELA Bio specializes in surgical technologies designed to preserve and restore a patient’s natural anatomy while reducing long-term reliance on permanent synthetic materials. The company has positioned its soft-tissue reconstruction solutions as economically efficient, clinically advanced alternatives for surgeons seeking improved patient outcomes.
TELA’s appearance at Piper Sandler’s conference reflects the company’s continued efforts to expand its visibility within the healthcare investment community as it advances commercialization of its biologic and hybrid reconstruction technologies.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.